Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-20 @ 5:26 AM
Study NCT ID:
NCT00970268
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2009-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-01
First Submit QC Date:
None
Study First Post Date:
2009-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-14
Results First Submit QC Date:
None
Results First Post Date:
2012-09-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-10-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-11-16
Last Update Post Date:
2017-01-06
Last Update Post Date Type:
ESTIMATED